medibill

Item 11220

OPTICAL COHERENCE TOMOGRAPHY for the assessment of the need for treatment following provision of pharmaceutical benefits scheme-subsidised ocriplasmin. Maximum of one service per eye per lifetime.

MBS Fee: $46.60

Practical Summary

Billing Options (Reference)

No alternatives identified yet.

Equivalent Items

None

Version History

Mon May 11 2026 00:17:26 GMT+0000 (Coordinated Universal Time): fee $46.60 | OPTICAL COHERENCE TOMOGRAPHY for the assessment of the need for treatment following provision of pharmaceutical benefits scheme-subsidised ocriplasmin. Maximum of one service per eye per lifetime.

This tool is for internal reference only. It is not legal, clinical, or billing advice. Clinicians and practices remain responsible for checking current official sources and claiming requirements.

Source attribution: MBS XML imported from mbsonline.gov.au with source URL, retrieval date, and version metadata retained in import records.